Logo image of ALREW.PA

REWORLD (ALREW.PA) Stock Fundamental Analysis

EPA:ALREW - Euronext Paris - Matif - FR0010820274 - Common Stock - Currency: EUR

1.674  -0.02 (-0.95%)

Fundamental Rating

5

Overall ALREW gets a fundamental rating of 5 out of 10. We evaluated ALREW against 62 industry peers in the Media industry. ALREW has an average financial health and profitability rating. ALREW may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ALREW had positive earnings in the past year.
In the past year ALREW had a positive cash flow from operations.
ALREW had positive earnings in each of the past 5 years.
ALREW had a positive operating cash flow in each of the past 5 years.
ALREW.PA Yearly Net Income VS EBIT VS OCF VS FCFALREW.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

With a decent Return On Assets value of 3.65%, ALREW is doing good in the industry, outperforming 67.74% of the companies in the same industry.
ALREW's Return On Equity of 10.95% is fine compared to the rest of the industry. ALREW outperforms 64.52% of its industry peers.
The Return On Invested Capital of ALREW (8.44%) is better than 75.81% of its industry peers.
ALREW had an Average Return On Invested Capital over the past 3 years of 10.02%. This is in line with the industry average of 8.25%.
Industry RankSector Rank
ROA 3.65%
ROE 10.95%
ROIC 8.44%
ROA(3y)4.63%
ROA(5y)4.84%
ROE(3y)15.78%
ROE(5y)17.69%
ROIC(3y)10.02%
ROIC(5y)11.09%
ALREW.PA Yearly ROA, ROE, ROICALREW.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

ALREW has a Profit Margin (4.36%) which is in line with its industry peers.
ALREW's Profit Margin has declined in the last couple of years.
ALREW has a Operating Margin of 8.81%. This is in the better half of the industry: ALREW outperforms 62.90% of its industry peers.
ALREW's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 61.10%, ALREW perfoms like the industry average, outperforming 59.68% of the companies in the same industry.
In the last couple of years the Gross Margin of ALREW has grown nicely.
Industry RankSector Rank
OM 8.81%
PM (TTM) 4.36%
GM 61.1%
OM growth 3Y-11.07%
OM growth 5Y-15.59%
PM growth 3Y-19.13%
PM growth 5Y-12.76%
GM growth 3Y-3.09%
GM growth 5Y19.36%
ALREW.PA Yearly Profit, Operating, Gross MarginsALREW.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ALREW is creating value.
ALREW has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALREW has more shares outstanding
ALREW has a better debt/assets ratio than last year.
ALREW.PA Yearly Shares OutstandingALREW.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ALREW.PA Yearly Total Debt VS Total AssetsALREW.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ALREW has an Altman-Z score of 1.72. This is a bad value and indicates that ALREW is not financially healthy and even has some risk of bankruptcy.
ALREW's Altman-Z score of 1.72 is in line compared to the rest of the industry. ALREW outperforms 58.06% of its industry peers.
The Debt to FCF ratio of ALREW is 10.26, which is on the high side as it means it would take ALREW, 10.26 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.26, ALREW is doing worse than 62.90% of the companies in the same industry.
ALREW has a Debt/Equity ratio of 0.87. This is a neutral value indicating ALREW is somewhat dependend on debt financing.
ALREW has a Debt to Equity ratio (0.87) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 10.26
Altman-Z 1.72
ROIC/WACC1.56
WACC5.41%
ALREW.PA Yearly LT Debt VS Equity VS FCFALREW.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ALREW has a Current Ratio of 1.52. This is a normal value and indicates that ALREW is financially healthy and should not expect problems in meeting its short term obligations.
ALREW has a Current ratio of 1.52. This is in the better half of the industry: ALREW outperforms 77.42% of its industry peers.
A Quick Ratio of 1.50 indicates that ALREW should not have too much problems paying its short term obligations.
The Quick ratio of ALREW (1.50) is better than 79.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.5
ALREW.PA Yearly Current Assets VS Current LiabilitesALREW.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The earnings per share for ALREW have decreased by -8.61% in the last year.
Measured over the past years, ALREW shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.09% on average per year.
ALREW shows a decrease in Revenue. In the last year, the revenue decreased by -2.65%.
The Revenue has been growing by 12.68% on average over the past years. This is quite good.
EPS 1Y (TTM)-8.61%
EPS 3Y-18.34%
EPS 5Y-6.09%
EPS Q2Q%17.2%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y4.41%
Revenue growth 5Y12.68%
Sales Q2Q%-4.34%

3.2 Future

The Earnings Per Share is expected to grow by 16.74% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.67% on average over the next years.
EPS Next Y15.91%
EPS Next 2Y14.15%
EPS Next 3Y16.74%
EPS Next 5YN/A
Revenue Next Year0.77%
Revenue Next 2Y1.47%
Revenue Next 3Y2.67%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALREW.PA Yearly Revenue VS EstimatesALREW.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALREW.PA Yearly EPS VS EstimatesALREW.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 0.6

9

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.65, the valuation of ALREW can be described as very cheap.
ALREW's Price/Earnings ratio is rather cheap when compared to the industry. ALREW is cheaper than 96.77% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALREW to the average of the S&P500 Index (27.45), we can say ALREW is valued rather cheaply.
ALREW is valuated cheaply with a Price/Forward Earnings ratio of 3.19.
Based on the Price/Forward Earnings ratio, ALREW is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, ALREW is valued rather cheaply.
Industry RankSector Rank
PE 4.65
Fwd PE 3.19
ALREW.PA Price Earnings VS Forward Price EarningsALREW.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALREW is valued a bit cheaper than 79.03% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALREW indicates a rather cheap valuation: ALREW is cheaper than 80.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.37
EV/EBITDA 3.59
ALREW.PA Per share dataALREW.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

ALREW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALREW has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ALREW's earnings are expected to grow with 16.74% in the coming years.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y14.15%
EPS Next 3Y16.74%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.18%, ALREW has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.99, ALREW has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.42, ALREW's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALREW.PA Yearly Dividends per shareALREW.PA Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.01 0.02

5.3 Sustainability

DPN/A
EPS Next 2Y14.15%
EPS Next 3Y16.74%
ALREW.PA Yearly Income VS Free CF VS DividendALREW.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

REWORLD

EPA:ALREW (7/4/2025, 7:00:00 PM)

1.674

-0.02 (-0.95%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)09-23 2025-09-23
Inst Owners14.74%
Inst Owner ChangeN/A
Ins Owners23.34%
Ins Owner ChangeN/A
Market Cap97.16M
Analysts89.09
Price Target4.62 (175.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.18%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.51%
Valuation
Industry RankSector Rank
PE 4.65
Fwd PE 3.19
P/S 0.18
P/FCF 5.37
P/OCF 3.64
P/B 0.46
P/tB N/A
EV/EBITDA 3.59
EPS(TTM)0.36
EY21.51%
EPS(NY)0.53
Fwd EY31.38%
FCF(TTM)0.31
FCFY18.63%
OCF(TTM)0.46
OCFY27.44%
SpS9.21
BVpS3.67
TBVpS-2.37
PEG (NY)0.29
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.65%
ROE 10.95%
ROCE 10.14%
ROIC 8.44%
ROICexc 10.38%
ROICexgc 143.53%
OM 8.81%
PM (TTM) 4.36%
GM 61.1%
FCFM 3.39%
ROA(3y)4.63%
ROA(5y)4.84%
ROE(3y)15.78%
ROE(5y)17.69%
ROIC(3y)10.02%
ROIC(5y)11.09%
ROICexc(3y)12.89%
ROICexc(5y)19.45%
ROICexgc(3y)259.8%
ROICexgc(5y)N/A
ROCE(3y)12.04%
ROCE(5y)13.33%
ROICexcg growth 3Y-90.01%
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.99%
ROICexc growth 5Y-22.15%
OM growth 3Y-11.07%
OM growth 5Y-15.59%
PM growth 3Y-19.13%
PM growth 5Y-12.76%
GM growth 3Y-3.09%
GM growth 5Y19.36%
F-Score7
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 10.26
Debt/EBITDA 3.39
Cap/Depr 111.17%
Cap/Sales 1.6%
Interest Coverage 250
Cash Conversion 48.64%
Profit Quality 77.74%
Current Ratio 1.52
Quick Ratio 1.5
Altman-Z 1.72
F-Score7
WACC5.41%
ROIC/WACC1.56
Cap/Depr(3y)78.11%
Cap/Depr(5y)67.07%
Cap/Sales(3y)1.5%
Cap/Sales(5y)1.51%
Profit Quality(3y)60.69%
Profit Quality(5y)85.44%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.61%
EPS 3Y-18.34%
EPS 5Y-6.09%
EPS Q2Q%17.2%
EPS Next Y15.91%
EPS Next 2Y14.15%
EPS Next 3Y16.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y4.41%
Revenue growth 5Y12.68%
Sales Q2Q%-4.34%
Revenue Next Year0.77%
Revenue Next 2Y1.47%
Revenue Next 3Y2.67%
Revenue Next 5YN/A
EBIT growth 1Y-16.61%
EBIT growth 3Y-7.15%
EBIT growth 5Y-4.89%
EBIT Next Year22.35%
EBIT Next 3Y12.34%
EBIT Next 5YN/A
FCF growth 1Y59.16%
FCF growth 3Y-14.06%
FCF growth 5YN/A
OCF growth 1Y23.54%
OCF growth 3Y-8.92%
OCF growth 5YN/A